RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Korean Society for Laboratory Medicine Practice Guidelines for the Molecular Diagnosis of Middle East Respiratory Syndrome During an Outbreak in Korea in 2015

      한글로보기

      https://www.riss.kr/link?id=A103365400

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      For two months between May and July 2015, a nationwide outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) occurred in Korea. On June 3, 2015, the Korean Society for Laboratory Medicine (KSLM) launched a MERS-CoV Laboratory Response Task Force (LR-TF) to facilitate clinical laboratories to set up the diagnosis of MERS-CoV infection. Based on the WHO interim recommendations, the Centers for Disease Control and Prevention of United States guidelines for MERS-CoV laboratory testing, and other available resources, the KSLM MERS-CoV LR-TF provided the first version of the laboratory practice guidelines for the molecular diagnosis of MERS-CoV to the clinical laboratories on June 12, 2015. The guidelines described here are an updated version that includes case definition, indications for testing, specimen type and protocols for specimen collection, specimen packing and transport, specimen handling and nucleic acid extraction, molecular detection of MERS-CoV, interpretation of results and reporting, and laboratory safety. The KSLM guidelines mainly focus on the molecular diagnosis of MERS-CoV, reflecting the unique situation in Korea and the state of knowledge at the time of publication.
      번역하기

      For two months between May and July 2015, a nationwide outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) occurred in Korea. On June 3, 2015, the Korean Society for Laboratory Medicine (KSLM) launched a MERS-CoV Laboratory Response Ta...

      For two months between May and July 2015, a nationwide outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) occurred in Korea. On June 3, 2015, the Korean Society for Laboratory Medicine (KSLM) launched a MERS-CoV Laboratory Response Task Force (LR-TF) to facilitate clinical laboratories to set up the diagnosis of MERS-CoV infection. Based on the WHO interim recommendations, the Centers for Disease Control and Prevention of United States guidelines for MERS-CoV laboratory testing, and other available resources, the KSLM MERS-CoV LR-TF provided the first version of the laboratory practice guidelines for the molecular diagnosis of MERS-CoV to the clinical laboratories on June 12, 2015. The guidelines described here are an updated version that includes case definition, indications for testing, specimen type and protocols for specimen collection, specimen packing and transport, specimen handling and nucleic acid extraction, molecular detection of MERS-CoV, interpretation of results and reporting, and laboratory safety. The KSLM guidelines mainly focus on the molecular diagnosis of MERS-CoV, reflecting the unique situation in Korea and the state of knowledge at the time of publication.

      더보기

      참고문헌 (Reference)

      1 Centers for Disease Control and Prevention, "interim patient under investigation (PUI) guidance and case definitions"

      2 WHO, "WHO Laboratory Biosafety Manual"

      3 Korea Center for Disease Control and Prevention, "The guideline for safe transportation of infectious substances"

      4 WHO, "Novel coronavirus 2012: Interim recommendations for laboratory biorisk management"

      5 Command and Control Center, "Ministry of Health, Kingdom of Saudi Arabia, The case definition for MERS-CoV infections approved by the ministry of health"

      6 WHO, "Middle Ease respiratory syndrome coronavirus. Case definition for reporting to WHO. Interim case definition as of 14 July 2015"

      7 WHO, "MERS-CoV in Republic of Korea at a glance as of 29 July 2015"

      8 Central MERS-CoV Control Office, "MERS Statistics"

      9 WHO, "Laboratory testing for Middle East Respiratory Syndrome Coronavirus. Interim guidance"

      10 Zaki AM, "Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia" 367 : 1814-1820, 2012

      1 Centers for Disease Control and Prevention, "interim patient under investigation (PUI) guidance and case definitions"

      2 WHO, "WHO Laboratory Biosafety Manual"

      3 Korea Center for Disease Control and Prevention, "The guideline for safe transportation of infectious substances"

      4 WHO, "Novel coronavirus 2012: Interim recommendations for laboratory biorisk management"

      5 Command and Control Center, "Ministry of Health, Kingdom of Saudi Arabia, The case definition for MERS-CoV infections approved by the ministry of health"

      6 WHO, "Middle Ease respiratory syndrome coronavirus. Case definition for reporting to WHO. Interim case definition as of 14 July 2015"

      7 WHO, "MERS-CoV in Republic of Korea at a glance as of 29 July 2015"

      8 Central MERS-CoV Control Office, "MERS Statistics"

      9 WHO, "Laboratory testing for Middle East Respiratory Syndrome Coronavirus. Interim guidance"

      10 Zaki AM, "Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia" 367 : 1814-1820, 2012

      11 Centers for Disease Control and Prevention, "Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – Version 2.1"

      12 Korea Centers for Disese Control and Prevention, "Instructions for the safe transport of infectious substances"

      13 Corman VM, "Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction" 17 : 2012

      14 Centers for Disease Control and Prevention, "CDC Laboratory Testing for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)"

      15 Corman VM, "Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections" 17 : 2012

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2012-05-21 학술지명변경 한글명 : The Korean Journal of Laboratory Medicine -> Annals of Laboratory Medicine
      외국어명 : The Korean Journal of Laboratory Medicine -> Annals of Laboratory Medicine
      KCI등재
      2011-01-01 평가 학술지 분리 (기타) KCI등재
      2010-06-29 학술지명변경 한글명 : 대한진단검사의학회지 -> The Korean Journal of Laboratory Medicine KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.51 0.18 1.15
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.91 0.81 0.458 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼